Back to Glossary
Sourcing

What is Excipient?

Pharmaceutical Excipient

Definition

An excipient is an inactive substance formulated alongside the active pharmaceutical ingredient — such as binders, fillers, preservatives, or stabilizers — that aids manufacturing, delivery, or stability.

Industry Context

Excipient sourcing and quality are part of a complete drug-product supply chain assessment.

What excipients do

An excipient has no therapeutic effect of its own, but a medicine cannot be made or work without it. Fillers such as lactose and microcrystalline cellulose give a tablet its bulk; binders such as povidone hold it together; disintegrants such as croscarmellose sodium make it break apart in the body; lubricants such as magnesium stearate stop it sticking to the press.

Others control where and how fast the drug is released (coating polymers), keep a liquid stable (buffers, preservatives, surfactants) or make an injectable possible at all (cyclodextrins, phospholipids). A few change how much drug is absorbed: salcaprozate sodium is the excipient that lets an oral peptide survive the stomach.

How excipients are regulated: the Type IV DMF

In the United States an excipient supplier can file a Type IV Drug Master File with the FDA. It holds the confidential manufacturing and control details, and a drug applicant references it with the holder's letter of authorisation. The FDA does not approve a DMF; it reviews it when an application relies on it.

A Type IV DMF is optional. Many well-established excipients are supplied against a pharmacopoeia monograph (USP-NF, Ph. Eur.) with no DMF at all, so a list of DMF holders is not a list of every supplier. In Europe an excipient with a monograph can instead hold an EDQM Certificate of Suitability.

What to check when sourcing an excipient

Start with the grade: the same substance is sold to different pharmacopoeia standards and in different physical forms, and a formulation is usually developed around one of them. Then confirm the regulatory support you need for your market (an active DMF you can be authorised to reference, or a CEP), the manufacturing site, and whether a second source exists for anything critical.

Novel excipients, and excipients used at a new level or by a new route, carry more regulatory work than established ones, because their safety has to be supported in the application itself.

Share this insight